Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
SI-BONE, Inc. SIBN
$24.70
+$1.5 (6.05%)
На 18:01, 12 мая 2023
-29.15%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
818382652.00000000
-
week52high
27.24
-
week52low
11.14
-
Revenue
106409000
-
P/E TTM
-14
-
Beta
0.94536500
-
EPS
-1.99000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 мая 2023 г. в 20:30
Описание компании
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | Buy | 09 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 09 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 июл 2022 г. |
| Needham | Buy | Buy | 10 мая 2022 г. |
| Morgan Stanley | Overweight | Overweight | 10 мая 2022 г. |
| Jefferies | Buy | 12 окт 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Needham | Buy | Buy | 08 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 08 ноя 2022 г. |
| JMP Securities | Market Outperform | Market Outperform | 08 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| Truist Securities | Buy | Buy | 20 дек 2022 г. |
| Truist Securities | Buy | Buy | 31 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| RECUPERO ANTHONY J | D | 237901 | 284 | 18 янв 2023 г. |
| Pisetsky Michael A | D | 172108 | 399 | 17 янв 2023 г. |
| DUNN JEFFREY W | D | 101992 | 1739 | 17 янв 2023 г. |
| RECUPERO ANTHONY J | D | 238185 | 1000 | 17 янв 2023 г. |
| RECUPERO ANTHONY J | D | 239185 | 664 | 17 янв 2023 г. |
| FRANCIS LAURA | A | 466651 | 70252 | 06 янв 2023 г. |
| FRANCIS LAURA | A | 396399 | 70252 | 06 янв 2023 г. |
| Maheshwari Anshul | A | 166124 | 19159 | 06 янв 2023 г. |
| Maheshwari Anshul | A | 146965 | 57478 | 06 янв 2023 г. |
| Pisetsky Michael A | A | 172507 | 56445 | 06 янв 2023 г. |
Новостная лента
Why Shares of Si-Bone Jumped Tuesday
The Motley Fool
02 мая 2023 г. в 14:12
Si-Bone makes the iFuse Implant System for the sacroiliac joint, found in the lower back. The company said it increased its surgeon base to 950 surgeons in the U.S. Revenue for Si-Bone was up 46% year over year.
SI-BONE, Inc. (SIBN) Q1 2023 Earnings Call Transcript
Seeking Alpha
01 мая 2023 г. в 22:20
SI-BONE, Inc. (NASDAQ:SIBN ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Drew Ranieri - Morgan Stanley Young Li - Jefferies Sam Brodovsky - Truist Dave Turkaly - JMP Securities Kyle Rose - Canaccord Ross Osborn - Cantor Fitzgerald David Saxon - Needham & Company Operator Good afternoon, and welcome to SI-BONE's First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
01 мая 2023 г. в 19:46
Si-Bone (SIBN) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.52 per share a year ago.
SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference
GlobeNewsWire
24 апр 2023 г. в 16:09
SANTA CLARA, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2023 Bank of America Merrill Lynch Global Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 9th, 2023, at 1:55 p.m. Eastern Time / 10:55 a.m. Pacific Time.
SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023
GlobeNewsWire
10 апр 2023 г. в 16:09
SANTA CLARA, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2023 after market close on Monday, May 1, 2023. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.